55 results
S-3ASR
EX-4.2
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
assessment or penalty or otherwise; it being expressly understood that this Indenture and the obligations issued hereunder are solely corporate obligations
S-3ASR
EX-4.3
AKRO
Akero Therapeutics Inc
10 May 24
Automatic shelf registration
4:57pm
such predecessor or successor corporation, whether by virtue of any constitution, statute or rule of law, or by the enforcement of any assessment
PRE 14A
AKRO
Akero Therapeutics Inc
16 Apr 24
Preliminary proxy
4:30pm
committee retains an independent compensation consultant to provide support in its review and assessment of our executive compensation program … compensation peer group;
the performance of each individual executive officer, based on an assessment of his or her contributions to our overall
424B5
4vbe6 b14m8tx
6 Mar 24
Prospectus supplement for primary offering
5:16pm
424B5
8pdi2v3lmkb6qwm
4 Mar 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
ah4fr640
29 Feb 24
Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
7:15am
8-K
EX-99.2
9fkx2e
5 Jun 23
Results of Operations and Financial Condition
8:05am
424B5
30j4e4y8s5t6m84h2
17 May 23
Prospectus supplement for primary offering
4:45pm
424B5
g2tky6
15 Sep 22
Prospectus supplement for primary offering
5:16pm
424B5
k39dc
13 Sep 22
Prospectus supplement for primary offering
5:11pm